First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in ChinaXueru Yin, Jinlin Hou, Guihua Zhuang et al.|Chinese Medical Journal|2019Cited by 8